Avalo Therapeutics grants options for 78,000 shares to six employees

Verifying
  • Avalo Therapeutics granted inducement stock options to six new employees.
  • The awards cover 78,000 shares at an exercise price of $19.34 each.
  • Avalo is advancing abdakibart into a phase 3 hidradenitis suppurativa program.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.